Clinical Research Directory
Browse clinical research sites, groups, and studies.
Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers
Sponsor: Queen Mary University of London
Summary
Urine and blood samples are being collected from patients with and without diseases of the pancreas. These samples will be tested with the aim of developing an accurate way of diagnosing diseases of the pancreas using the results.
Official title: Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers (UroPanc)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
3500
Start Date
2020-01-01
Completion Date
2026-08-31
Last Updated
2026-04-07
Healthy Volunteers
Yes
Conditions
Locations (4)
EUROPAC study, University of Liverpool
Liverpool, United Kingdom
ADEPTS study, University College London
London, United Kingdom
Imperial College London
London, United Kingdom
Royal London Hospital
London, United Kingdom